Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology, shared a post on X:
“Our new review is OUT! Targeting claudins in gastric cancer
From tight junction biology to real clinical impact.
- CLDN18.2: from ‘hidden’ protein to actionable target.
- Beyond mAbs – ADCs, bsAbs and CAR-T incoming.
- CLDN6 and CLDN1 emerging as the next frontiers.
- Expression ≠ accessibility – biology matters.
Time to CLAUD-in on the opportunity and let gastric cancer finally GLOW in the SPOTLIGHT Thank you Dr Mirallas, EduardoTB, CalvoMariona, Buges Cris, Robert Montal for your great work! And special thanks to Dr. Chierro Carbo for her invaluable teaching and inspiration!”
Title: Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT
Authors: Mario Balsa, Sergio Alonso, Laura Sánchez, Cristina Bugés, Laura Layos, Mariona Calvo, Elisenda Garsot, Marta Viciano, Arantxa Clavell, Raquel López, Hugo Uchima, Raquel Muñoz, Raquel Muriel, Beatriz González, Oriol Mirallas, Mariela Blum Murphy, Eduardo Terán, Robert Montal, Tania Fleitas, Cinta Hierro
Read the full article on ScienceDirect.
Other articles featuring Mario Balsa on OncoDaily.
